ALISO VIEJO, Calif., Sept. 9 Clarient, Inc., a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the biopharmaceutical industry, today announced that the Company's presentation time at the Baird 2010 Health Care Conference has changed to 9:00 am EDT on Tuesday, September 14, 2010.
ATLANTA, Sept. 9 Gentiva Health Services, Inc., the nation's largest provider of home health and hospice services, announced today that it will present at the Baird 2010 Health Care Conference in New York at 8:30 a.m. ET on Wednesday, September 15, 2010 and the Stifel Nicolaus 2010 Health Care Conference in Boston at 2:05 p.m. ET on Thursday, Septe
New App for iPhone and iPod touch Allows Members to Connect to Their Accounts, Conduct Business and Quickly Access Vital Information. Members of Health Net, Inc. now have mobile access to their accounts and other key details - like maps and directions to their nearest urgent care center - providing on-the-go capabilities to conduct business and qui
MONTEREY, Calif., Sept. 9 Language Line Services, the leading provider of language-based solutions and the number one provider of over-the-phone interpreting services for the healthcare industry, announced a program of support, instructional materials and consultations to help ensure compliance for hospitals as they gear up for the new Joint Commis
Healthcare supplier Perrigo Company declared on Wednesday the receipt of approval from the US Food and Drug Administration to manufacture and market Imiquimod Cream, 5%. The company said it will vertically integrate Imiquimod Cream, 5% with its own API.
A new study, 'Sunlight robbery: a critique of public health policy on vitamin D in the UK,' is now available. "Few food products are fortified with vitamin D in the UK and the government does not recommend any vitamin D supplement for most adults in the UK.
SYSPRO, the leading provider of visionary, pragmatic ERP software, announced that the company is highly confident that the SYSPRO ERP solution will enable pharmaceutical manufacturers to meet the new U.S. Food and Drug Administration regulations being proposed by Congress. Traceability functionality is the key component required to assist in the me
Alexion Pharmaceuticals, Inc. announced that the US Food and Drug Administration has approved Alexion's Rhode Island manufacturing facility in Smithfield, Rhode Island as a second source of commercial supply for Soliris. Earlier this year, Alexion reported that the European Medicines Agency had approved ARIMF as a second source of supply for Soli
Item 8.01. On September 8, 2010, BioMimetic Therapeutics, Inc. issued a press release that announced it completed its 100 day Premarket Approval Application meeting with the Food and Drug Administration regarding the review of Augment Bone Graft for the treatment of foot and ankle fusions in the United States. The Company continues to anticipate th
Columbus, Ind. Columbus Regional Hospital is bringing the nation's largest health information exchange to the Columbus, Ind. area to better serve patients.
WOONSOCKET, R.I., Sept. 8 CVS Caremark announced today that it will partner with Direct Relief USA to offer up to $5 million in free flu shots to community clinic and health center patients who lack health insurance. Flu vaccinations are now available at all CVS/pharmacy and MinuteClinic locations nationwide.
NEW YORK, Sept. 8 Delcath Systems, Inc. announced today that management will present at CL King's 8th Annual Best Ideas Conference on Wednesday, September 15, 2010 at 10:00 a.m. ET in New York, NY. Mr. David McDonald, Chief Financial Officer, will provide an overview of the Company's business strategy and recent corporate developments. Attendance
WEST CHESTER, PA, Sept. 8 DiagnoCure Oncology Laboratories, the U.S. subsidiary of DiagnoCure, Inc., announced that Valerie Palmieri, President of the U.S. operation, will present an overview of the laboratory's plans for a colorectal cancer disease management program at the Rodman & Renshaw Annual Global Investment Conference on Wednesday, Septemb
Pharmaceutical company Forest Laboratories Inc revealed on Tuesday that a US Food and Drug Administration advisory committee has recommended approval of the companyEURs ceftaroline fosamil for the treatment of community acquired bacterial pneumonia and complicated skin and skin structure infections.
- Model Serves as a Bridge to Health Care Reform Requirements - MAXIMUS announced today that it has signed a new contract with the Colorado Department of Health Care Policy and Financing to help Colorado modernize eligibility and enrollment for its Medical Assistance programs, including Medicaid and the Children's Health Insurance Program . The fiv
Neuralstem, Inc. announced that it has filed an Investigational New Drug application with the United States Food and Drug Administration to begin a Phase I safety clinical trial for chronic spinal cord injury with its spinal cord stem cells.
Investigators publish new data in the report 'Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial.'
Research findings, 'Insertion of the Mirena intrauterine system for treatment of adenomyosis-associated menorrhagia: a novel method,' are discussed in a new report. "This retrospective study enrolled 273 patients with adenomyosis who were receiving Mirena for treatment of menorrhagia and/or dysmenorrhea between 2001 and 2008.
New Relevancy for Social Learning and Mobile Messaging in Medicine, Announces InQuill Medical Communications, LLC. InQuill Medical Communications, LLC today announced partnerships with social media start-ups Medikly, LLC and 2digiti, LLC to enhance health professional continuing education and patient care.
The US Food and Drug Administration approved Tekamlo tablets, a single-pill for the treatment of high blood pressure combining the only approved direct renin inhibitor, Tekturna, with the widely used calcium channel blocker amlodipine.
Palomar Medical Technologies, Inc. is skyrocketing on news it received FDA approval for its powered laser surgical instrument with microbeam\fractional output. Here is the link to the FDA approval. Shares of PMTI are higher by 4.7% today.
Shire plc, the global specialty. biopharmaceutical company, announces that its subsidiary Shire Pharmaceuticals Inc. received a ruling from the FDA on its Citizen's Petition relating to Pentasa. The ruling granted-in-part and denied-in-part the requests from Shire.
Perrigo Company announced it received FDA approval from the U.S. Food and Drug Administration to manufacture and market Imiquimod Cream, 5%. Perrigo will vertically integrate this product with their own API.
ALLEGAN, Mich., Sept. 8 Perrigo Company announced it received FDA approval from the U.S. Food and Drug Administration to manufacture and market Imiquimod Cream, 5%. Perrigo will vertically integrate this product with their own API.
ALLEGAN, Mich. Aldara, made by Graceway Pharmaceuticals, is also used for superficial basal cell carcinoma and external genital and perianal warts in patients 12 years old or older. In addition to making pharmaceutical products, Perrigo, which is based in Allegan, Mich., makes infant formulas, nutritional products and pharmaceutical and medical dia
